Dysregulation of SIRT-1 in aging mice increases skeletal muscle fatigue by a PARP-1-dependent mechanism

Aging

Volumn 6, Issue 10, 2014, Pages 820-834

  Mohamed, Junaith S ^a   Wilson, Joseph C ^a   Myers, Matthew J ^a   Sisson, Kayla J ^a   Alway, Stephen E ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Oxidative stress; PARP 1; Sarcopenia; SIRT 1; Skeletal muscle

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PARP1 PROTEIN, MOUSE; SIRT1 PROTEIN, MOUSE; SIRTUIN 1; SMALL INTERFERING RNA;

AGING; ANIMAL; ANIMAL EXPERIMENT; C57BL MOUSE; GENETIC TRANSFECTION; IMMUNOBLOTTING; METABOLISM; MOUSE; MUSCLE FATIGUE; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOPENIA; SKELETAL MUSCLE;

AGING; ANIMALS; IMMUNOBLOTTING; MICE; MICE, INBRED C57BL; MUSCLE FATIGUE; MUSCLE, SKELETAL; PHYSICAL CONDITIONING, ANIMAL; POLY(ADP-RIBOSE) POLYMERASES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SARCOPENIA; SIRTUIN 1; TRANSFECTION;

EID: 84923107636     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100696     Document Type: Article

References (61)

1. Welch AA, MacGregor AJ, Minihane AM, Skinner J, Valdes AA, Spector TD and Cassidy A. Dietary fat and fatty acid profile are associated with indices of skeletal muscle mass in women aged 18-79 years. J Nutr. 2014; 144:327-334.
2. Prado CM, Wells JC, Smith SR, Stephan BC and Siervo M. Sarcopenic obesity: A Critical appraisal of the current evidence. Clin Nutr. 2012; 31:583-601.
3. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997; 127(5 Suppl):990S-991S.
4. Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, Abellan Van Kan G, Andrieu S, Bauer J, Breuille D, Cederholm T, Chandler J, De Meynard C, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011; 12:249-256.
5. Ghosh S, Lertwattanarak R, Garduno JD, Galeana JJ, Li J, Zamarripa F, Lancaster JL, Mohan S, Hussey S and Musi N. Elevated Muscle TLR4 Expression and Metabolic Endotoxemia in Human Aging. J Gerontol A Biol Sci Med Sci. 2014.
6. Jang YC, Sinha M, Cerletti M, Dall'Osso C and Wagers AJ. Skeletal muscle stem cells: effects of aging and metabolism on muscle regenerative function. Cold Spring Harb Symp Quant Biol. 2011; 76:101-111.
7. Garcia-Prat L, Sousa-Victor P and Munoz-Canoves P. Functional dysregulation of stem cells during aging: a focus on skeletal muscle stem cells. FEBS J. 2013; 280:4051-4062.
8. Sousa-Victor P, Gutarra S, Garcia-Prat L, Rodriguez-Ubreva J, Ortet L, Ruiz-Bonilla V, Jardi M, Ballestar E, Gonzalez S, Serrano AL, Perdiguero E and Munoz-Canoves P. Geriatric muscle stem cells switch reversible quiescence into senescence. Nature. 2014; 506:316-321.
9. Ryan MJ, Jackson JR, Hao Y, Leonard SS and Alway SE. Inhibition of xanthine oxidase reduces oxidative stress and improves skeletal muscle function in response to electrically stimulated isometric contractions in aged mice. Free Radic Biol Med. 2011; 51:38-52.
10. Fulle S, Protasi F, Di Tano G, Pietrangelo T, Beltramin A, Boncompagni S, Vecchiet L and Fano G. The contribution of reactive oxygen species to sarcopenia and muscle ageing. Exp Gerontol. 2004; 39:17-24.
11. Ji LL. Antioxidant signaling in skeletal muscle: a brief review. Exp Gerontol. 2007; 42:582-593.
12. Vays VB, Eldarov CM, Vangely IM, Kolosova NG, Bakeeva LE and Skulachev VP. Antioxidant SkQ1 delays sarcopeniaassociated damage of mitochondrial ultrastructure. Aging (Albany NY). 2014; 6:140-148.
13. Jungmichel S, Rosenthal F, Altmeyer M, Lukas J, Hottiger MO and Nielsen ML. Proteome-wide identification of poly(ADPRibosyl) ation targets in different genotoxic stress responses. Mol Cell. 2013; 52:272-285.
14. Schreiber V, Dantzer F, Ame JC and de Murcia G. Poly(ADPribose): novel functions for an old molecule. Nat Rev Mol Cell Biol. 2006; 7:517-528.
15. Hottiger MO, Hassa PO, Luscher B, Schuler H and Koch-Nolte F. Toward a unified nomenclature for mammalian ADPribosyltransferases. Trends Biochem Sci. 2010; 35:208-219.
16. Woodhouse BC and Dianov GL. Poly ADP-ribose polymerase-1: an international molecule of mystery. DNA Repair (Amst). 2008; 7:1077-1086.
17. ++ into a nuclear signal. Genes Dev. 2005; 19:1951-1967.
18. Kraus WL. Transcriptional control by PARP-1: chromatin modulation, enhancer-binding, coregulation, and insulation. Curr Opin Cell Biol. 2008; 20:294-302.
19. Ha HC and Snyder SH. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci U S A. 1999; 96:13978-13982.
20. Ingram DK, Zhu M, Mamczarz J, Zou S, Lane MA, Roth GS and deCabo R. Calorie restriction mimetics: an emerging research field. Aging Cell. 2006; 5:97-108.
21. Colman RJ, Anderson RM, Johnson SC, Kastman EK, Kosmatka KJ, Beasley TM, Allison DB, Cruzen C, Simmons HA, Kemnitz JW and Weindruch R. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science. 2009; 325:201-204.
22. Chen D, Steele AD, Lindquist S and Guarente L. Increase in activity during calorie restriction requires Sirt1. Science. 2005; 310:1641.
23. Li Y, Xu W, McBurney MW and Longo VD. SirT1 inhibition reduces IGF-I/IRS-2/Ras/ERK1/2 signaling and protects neurons. Cell Metab. 2008; 8:38-48.
24. Oberdoerffer P, Michan S, McVay M, Mostoslavsky R, Vann J, Park SK, Hartlerode A, Stegmuller J, Hafner A, Loerch P, Wright SM, Mills KD, Bonni A, et al. SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell. 2008; 135:907-918.
25. Spindler SR. Caloric restriction: from soup to nuts. Ageing Res Rev. 2010; 9:324-353.
26. Yu J and Auwerx J. Protein deacetylation by SIRT1: an emerging key post-translational modification in metabolic regulation. Pharmacol Res. 2010; 62:35-41.
27. Vinciguerra M, Fulco M, Ladurner A, Sartorelli V and Rosenthal N. SirT1 in muscle physiology and disease: lessons from mouse models. Dis Model Mech. 2010; 3:298-303.
28. Fulco M, Schiltz RL, Iezzi S, King MT, Zhao P, Kashiwaya Y, Hoffman E, Veech RL and Sartorelli V. Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. Mol Cell. 2003; 12:51-62.
29. Rathbone CR, Booth FW and Lees SJ. Sirt1 increases skeletal muscle precursor cell proliferation. Eur J Cell Biol. 2009; 88:35-44.
30. Machida S and Booth FW. Increased nuclear proteins in muscle satellite cells in aged animals as compared to young growing animals. Exp Gerontol. 2004; 39:1521-1525.
31. Gurd BJ, Yoshida Y, McFarlan JT, Holloway GP, Moyes CD, Heigenhauser GJ, Spriet L and Bonen A. Nuclear SIRT1 activity, but not protein content, regulates mitochondrial biogenesis in rat and human skeletal muscle. Am J Physiol Regul Integr Comp Physiol. 2011; 301:R67-75.
32. Bai P, Canto C, Oudart H, Brunyanszki A, Cen Y, Thomas C, Yamamoto H, Huber A, Kiss B, Houtkooper RH, Schoonjans K, Schreiber V, Sauve AA, et al. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab. 2011; 13:461-468.
33. Bai P, Canto C, Brunyanszki A, Huber A, Szanto M, Cen Y, Yamamoto H, Houten SM, Kiss B, Oudart H, Gergely P, Menissier-de Murcia J, Schreiber V, et al. PARP-2 regulates SIRT1 expression and whole-body energy expenditure. Cell Metab. 2011; 13:450-460.
34. Sauve AA, Moir RD, Schramm VL and Willis IM. Chemical activation of Sir2-dependent silencing by relief of nicotinamide inhibition. Mol Cell. 2005; 17:595-601.
35. ++ depletion and reduced Sir2alpha deacetylase activity. J Biol Chem. 2005; 280:43121-43130.
36. Adamietz P. Poly(ADP-ribose) synthase is the major endogenous nonhistone acceptor for poly(ADP-ribose) in alkylated rat hepatoma cells. Eur J Biochem. 1987; 169:365-372.
37. Rajamohan SB, Pillai VB, Gupta M, Sundaresan NR, Birukov KG, Samant S, Hottiger MO and Gupta MP. SIRT1 promotes cell survival under stress by deacetylation-dependent deactivation of poly(ADP-ribose) polymerase 1. Mol Cell Biol. 2009; 29:4116-4129.
38. Ryan MJ, Jackson JR, Hao Y, Williamson CL, Dabkowski ER, Hollander JM and Alway SE. Suppression of oxidative stress by resveratrol after isometric contractions in gastrocnemius muscles of aged mice. J Gerontol A Biol Sci Med Sci. 2010; 65:815-831.
39. Hassa PO, Haenni SS, Buerki C, Meier NI, Lane WS, Owen H, Gersbach M, Imhof R and Hottiger MO. Acetylation of poly(ADPribose) polymerase-1 by p300/CREB-binding protein regulates coactivation of NF-kappaB-dependent transcription. J Biol Chem. 2005; 280:40450-40464.
40. Bejma J and Ji LL. Aging and acute exercise enhance free radical generation in rat skeletal muscle. J Appl Physiol (1985). 1999; 87:465-470.
41. Gibson GE, Zhang H, Xu H, Park LC and Jeitner TM. Oxidative stress increases internal calcium stores and reduces a key mitochondrial enzyme. Biochim Biophys Acta. 2002; 1586:177-189.
42. Schraufstatter IU, Hyslop PA, Hinshaw DB, Spragg RG, Sklar LA and Cochrane CG. Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase. Proc Natl Acad Sci U S A. 1986; 83:4908-4912.
43. Virag L and Szabo C. The therapeutic potential of poly(ADPribose) polymerase inhibitors. Pharmacol Rev. 2002; 54:375-429.
44. Tonkin J, Villarroya F, Puri PL and Vinciguerra M. SIRT1 signaling as potential modulator of skeletal muscle diseases. Curr Opin Pharmacol. 2012; 12:372-376.
45. Joseph AM, Malamo AG, Silvestre J, Wawrzyniak N, Carey-Love S, Nguyen LM, Dutta D, Xu J, Leeuwenburgh C and Adhihetty PJ. Short-term caloric restriction, resveratrol, or combined treatment regimens initiated in late-life alter mitochondrial protein expression profiles in a fiber-type specific manner in aged animals. Exp Gerontol. 2013; 48:858-868.
46. Pardo PS, Mohamed JS, Lopez MA and Boriek AM. Induction of Sirt1 by mechanical stretch of skeletal muscle through the early response factor EGR1 triggers an antioxidative response. J Biol Chem. 2011; 286:2559-2566.
47. +(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell. 2013; 155:1624-1638.
48. Williamson DL. Normalizing a hyperactive mTOR initiates muscle growth during obesity. Aging (Albany NY). 2011; 3:83-84.
49. Leontieva OV and Blagosklonny MV. M(o)TOR of pseudohypoxic state in aging: rapamycin to the rescue. Cell Cycle. 2014; 13:509-515.
50. Smith BC, Hallows WC and Denu JM. A continuous microplate assay for sirtuins and nicotinamide-producing enzymes. Anal Biochem. 2009; 394:101-109.
51. Gurd BJ, Perry CG, Heigenhauser GJ, Spriet LL and Bonen A. High-intensity interval training increases SIRT1 activity in human skeletal muscle. Appl Physiol Nutr Metab. 2010; 35:350-357.
52. Bennett BT, Mohamed JS and Alway SE. Effects of resveratrol on the recovery of muscle mass following disuse in the plantaris muscle of aged rats. PLoS One. 2013; 8:e83518.
53. Jackson JR, Ryan MJ, Hao Y and Alway SE. Mediation of endogenous antioxidant enzymes and apoptotic signaling by resveratrol following muscle disuse in the gastrocnemius muscles of young and old rats. Am J Physiol Regul Integr Comp Physiol. 2010; 299:R1572-1581.
54. Gurd BJ. Deacetylation of PGC-1alpha by SIRT1: importance for skeletal muscle function and exercise-induced mitochondrial biogenesis. Appl Physiol Nutr Metab. 2011; 36:589-597.
55. Yang XJ, Ogryzko VV, Nishikawa J, Howard BH and Nakatani Y. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature. 1996; 382:319-324.
56. Kanai M, Hanashiro K, Kim SH, Hanai S, Boulares AH, Miwa M and Fukasawa K. Inhibition of Crm1-p53 interaction and nuclear export of p53 by poly(ADP-ribosyl)ation. Nat Cell Biol. 2007; 9:1175-1183.
57. Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L and Gu W. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell. 2001; 107:137-148.
58. Wong K, Zhang J, Awasthi S, Sharma A, Rogers L, Matlock EF, Van Lint C, Karpova T, McNally J and Harrod R. Nerve growth factor receptor signaling induces histone acetyltransferase domain-dependent nuclear translocation of p300/CREB-binding protein-associated factor and hGCN5 acetyltransferases. J Biol Chem. 2004; 279:55667-55674.
59. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA and Mayo MW. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004; 23:2369-2380.
60. Mohamed JS, Lopez MA, Cox GA and Boriek AM. Ankyrin repeat domain protein 2 and inhibitor of DNA binding 3 cooperatively inhibit myoblast differentiation by physical interaction. J Biol Chem. 2013; 288(34):24560-24568.
61. Mohamed JS, Hajira A, Pardo PS and Boriek AM. MicroRNA-149 inhibits PARP-2 and promotes mitochondrial biogenesis via SIRT-1/PGC-1alpha network in skeletal muscle. Diabetes. 2014; 63:1546-1559.